PUVA: A caution

S. Segal, S. N. Cohen, J. Freeman

Research output: Contribution to journalArticle

Abstract

A new investigational treatment for severe psoriasis has been introduced, but it is being widely used in an uncontrolled fashion. This treatment is a form of photochemotherapy known as PUVA (psoralen with ultraviolet light in the A range) and consists of total body irradiation with high-intensity, long-wave-length, ultraviolet light of a narrow band (320 to 400 nm) after oral administration of 8-methoxypsoralen (methoxsalen). Under no circumstances should children be treated with PUVA, except under established IND (investigational new drug) protocols.

Original languageEnglish (US)
Pages (from-to)253
Number of pages1
JournalPediatrics
Volume62
Issue number2
StatePublished - 1978
Externally publishedYes

Fingerprint

Ultraviolet Rays
Investigational Drugs
Methoxsalen
Ficusin
Investigational Therapies
Whole-Body Irradiation
Photochemotherapy
Psoriasis
Oral Administration
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Segal, S., Cohen, S. N., & Freeman, J. (1978). PUVA: A caution. Pediatrics, 62(2), 253.

PUVA : A caution. / Segal, S.; Cohen, S. N.; Freeman, J.

In: Pediatrics, Vol. 62, No. 2, 1978, p. 253.

Research output: Contribution to journalArticle

Segal, S, Cohen, SN & Freeman, J 1978, 'PUVA: A caution', Pediatrics, vol. 62, no. 2, pp. 253.
Segal S, Cohen SN, Freeman J. PUVA: A caution. Pediatrics. 1978;62(2):253.
Segal, S. ; Cohen, S. N. ; Freeman, J. / PUVA : A caution. In: Pediatrics. 1978 ; Vol. 62, No. 2. pp. 253.
@article{b9f34f14757e4f47afbe74a74ab6f15f,
title = "PUVA: A caution",
abstract = "A new investigational treatment for severe psoriasis has been introduced, but it is being widely used in an uncontrolled fashion. This treatment is a form of photochemotherapy known as PUVA (psoralen with ultraviolet light in the A range) and consists of total body irradiation with high-intensity, long-wave-length, ultraviolet light of a narrow band (320 to 400 nm) after oral administration of 8-methoxypsoralen (methoxsalen). Under no circumstances should children be treated with PUVA, except under established IND (investigational new drug) protocols.",
author = "S. Segal and Cohen, {S. N.} and J. Freeman",
year = "1978",
language = "English (US)",
volume = "62",
pages = "253",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - PUVA

T2 - A caution

AU - Segal, S.

AU - Cohen, S. N.

AU - Freeman, J.

PY - 1978

Y1 - 1978

N2 - A new investigational treatment for severe psoriasis has been introduced, but it is being widely used in an uncontrolled fashion. This treatment is a form of photochemotherapy known as PUVA (psoralen with ultraviolet light in the A range) and consists of total body irradiation with high-intensity, long-wave-length, ultraviolet light of a narrow band (320 to 400 nm) after oral administration of 8-methoxypsoralen (methoxsalen). Under no circumstances should children be treated with PUVA, except under established IND (investigational new drug) protocols.

AB - A new investigational treatment for severe psoriasis has been introduced, but it is being widely used in an uncontrolled fashion. This treatment is a form of photochemotherapy known as PUVA (psoralen with ultraviolet light in the A range) and consists of total body irradiation with high-intensity, long-wave-length, ultraviolet light of a narrow band (320 to 400 nm) after oral administration of 8-methoxypsoralen (methoxsalen). Under no circumstances should children be treated with PUVA, except under established IND (investigational new drug) protocols.

UR - http://www.scopus.com/inward/record.url?scp=0018101719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018101719&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018101719

VL - 62

SP - 253

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -